Mikkelsen, S. U., Kjær, L., Bjørn, M. E., Knudsen, T. A., Sørensen, A. L., Andersen, C. B. L., . . . Hasselbalch, H. C. (2018). Safety and efficacy of combination therapy of interferon‐α2 and ruxolitinib in polycythemia vera and myelofibrosis. Cancer Med.
Chicago Stili AlıntıMikkelsen, Stine Ulrik, et al. "Safety and Efficacy of Combination Therapy of Interferon‐α2 and Ruxolitinib in Polycythemia Vera and Myelofibrosis." Cancer Med 2018.
MLA AlıntıMikkelsen, Stine Ulrik, et al. "Safety and Efficacy of Combination Therapy of Interferon‐α2 and Ruxolitinib in Polycythemia Vera and Myelofibrosis." Cancer Med 2018.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..